Pharmaceuticals innovation expenditure Germany| ��ƽ��

Innovation expenditure in the manufacturing of pharmaceutical products industry in Germany from 2008 to 2025 (in billion euros)

Characteristic	Innovation expenditure in billion euros
2008	6.5
2009	6.2
2010	6.1
2011	6.8
2012	7.4
2013	8.2
2014	8.5
2015	9.1
2016	8.9
2017	11
2018	10.7
2019	11.5
2020	10.9
2021	10.6
2022	10.8
2023	11.6
2024¹	12.4
2025¹	12.8

Download

Source

Show detailed source information?

Already a member?

Source

Release date

January 2025

More information

Region

Germany

Survey time period

2008 to 2025

Special properties

Companies with at least five employees

Supplementary notes

¹ Target figures.

The German innovation survey is carried out on behalf of the Federal Ministry of Education and Research (BMBF) by the Center for European Economic Research (ZEW, Mannheim) in collaboration with infas (Institute for Applied Social Science) and the Fraunhofer Institute for Systems and Innovation Research (ISI). The survey is aimed at all companies in Germany with at least 5 employees. The definitions and measurement concepts correspond to the international standards of OECD and Eurostat. The innovation survey is part of the Europe-wide innovation survey (Community Innovation Survey - CIS) coordinated by Eurostat every two years. All values are extrapolated to the population of companies with 5 or more employees in Germany. A total of more than 15,300 companies took part in the 2024 innovation survey (= 56% of the sample size), including 113 from the pharmaceutical industry.

Citation formats

In 2025, around 12.8 billion euros of expenditure was planned for pharmaceutical product innovation in Germany. This is the most since 2008. There has been a steady rise in the amount of money spent on pharmaceutical innovations in Germany in recent years.